These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 31884479)
21. Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities. O'Riordan S; McMonagle P; Janssen JC; Fox NC; Farrell M; Collinge J; Rossor MN; Hutchinson M Neurology; 2002 Oct; 59(7):1108-10. PubMed ID: 12370477 [TBL] [Abstract][Full Text] [Related]
22. A novel presenilin-1 mutation (Leu85Pro) in early-onset Alzheimer disease with spastic paraparesis. Ataka S; Tomiyama T; Takuma H; Yamashita T; Shimada H; Tsutada T; Kawabata K; Mori H; Miki T Arch Neurol; 2004 Nov; 61(11):1773-6. PubMed ID: 15534188 [TBL] [Abstract][Full Text] [Related]
23. Autosomal dominant early onset Alzheimer's disease in the Mexican state of Jalisco: High frequency of the mutation PSEN1 c.1292C>A and phenotypic profile of patients. Dumois-Petersen S; Gallegos-Arreola MP; Magaña-Torres MT; Perea-Díaz FJ; Ringman JM; Figuera LE Am J Med Genet C Semin Med Genet; 2020 Dec; 184(4):1023-1029. PubMed ID: 33274538 [TBL] [Abstract][Full Text] [Related]
24. Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Mondadori CR; Buchmann A; Mustovic H; Schmidt CF; Boesiger P; Nitsch RM; Hock C; Streffer J; Henke K Brain; 2006 Nov; 129(Pt 11):2908-22. PubMed ID: 17012294 [TBL] [Abstract][Full Text] [Related]
25. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers. Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247 [TBL] [Abstract][Full Text] [Related]
27. Spastic paraparesis and atypical dementia caused by PSEN1 mutation (P264L), responsible for Alzheimer's disease. Jacquemont ML; Campion D; Hahn V; Tallaksen C; Frebourg T; Brice A; Durr A J Med Genet; 2002 Feb; 39(2):E2. PubMed ID: 11836371 [No Abstract] [Full Text] [Related]
28. Genetic influences on white matter and metabolism abnormal change in Alzheimer's disease: Meta-analysis for neuroimaging research on presenilin 1 mutation. Gu X; Chu T; Liu L; Han X Clin Neurol Neurosurg; 2019 Feb; 177():47-53. PubMed ID: 30599314 [TBL] [Abstract][Full Text] [Related]
29. A large family with hereditary spastic paraparesis due to a frame shift mutation of the spastin (SPG4) gene: association with multiple sclerosis in two affected siblings and epilepsy in other affected family members. Mead SH; Proukakis C; Wood N; Crosby AH; Plant GT; Warner TT J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):788-91. PubMed ID: 11723204 [TBL] [Abstract][Full Text] [Related]
30. Clinical characterization of a presenilin 1 mutation (F177S) in a family with very early-onset Alzheimer's disease in the third decade of life. Hausner L; Tschäpe JA; Schmitt HP; Hentschel F; Hartmann T; Frölich L Alzheimers Dement; 2014 Mar; 10(2):e27-39. PubMed ID: 23850332 [TBL] [Abstract][Full Text] [Related]
31. Very Early-Onset Alzheimer's Disease in the Third Decade of Life with de novo PSEN1 Mutations. Chen KL; Li PX; Sun YM; Chen SF; Zuo CT; Wang J; Dong Q; Cui M; Yu JT J Alzheimers Dis; 2022; 85(1):65-71. PubMed ID: 34776449 [TBL] [Abstract][Full Text] [Related]
32. Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis. Lyoo CH; Cho H; Choi JY; Hwang MS; Hong SK; Kim YJ; Ryu YH; Lee MS J Alzheimers Dis; 2016; 51(3):671-5. PubMed ID: 26890779 [TBL] [Abstract][Full Text] [Related]
34. Alteration of regional homogeneity and white matter hyperintensities in amnestic mild cognitive impairment subtypes are related to cognition and CSF biomarkers. Luo X; Jiaerken Y; Huang P; Xu XJ; Qiu T; Jia Y; Shen Z; Guan X; Zhou J; Zhang M; Brain Imaging Behav; 2018 Feb; 12(1):188-200. PubMed ID: 28236166 [TBL] [Abstract][Full Text] [Related]
35. The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: an additional fifteen families. Murrell J; Ghetti B; Cochran E; Macias-Islas MA; Medina L; Varpetian A; Cummings JL; Mendez MF; Kawas C; Chui H; Ringman JM Neurogenetics; 2006 Nov; 7(4):277-9. PubMed ID: 16897084 [TBL] [Abstract][Full Text] [Related]
36. Correlation between White Matter Hyperintensities Related Gray Matter Volume and Cognition in Cerebral Small Vessel Disease. Wang Y; Yang Y; Wang T; Nie S; Yin H; Liu J J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105275. PubMed ID: 32992182 [TBL] [Abstract][Full Text] [Related]
37. Presenilin-1 mutations in Alzheimer's disease: an update on genotype-phenotype relationships. Larner AJ J Alzheimers Dis; 2013; 37(4):653-9. PubMed ID: 23948899 [TBL] [Abstract][Full Text] [Related]
38. Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation. Carecchio M; Picillo M; Valletta L; Elia AE; Haack TB; Cozzolino A; Vitale A; Garavaglia B; Iuso A; Bagella CF; Pappatà S; Barone P; Prokisch H; Romito L; Tiranti V Neurogenetics; 2017 Jul; 18(3):175-178. PubMed ID: 28664294 [TBL] [Abstract][Full Text] [Related]
39. Association of serum cystatin C with white matter abnormalities in patients with amnestic mild cognitive impairment. Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Okita M; Shimizu S; Kanetaka H; Umahara T; Sakurai H; Hanyu H Geriatr Gerontol Int; 2019 Oct; 19(10):1036-1040. PubMed ID: 31489777 [TBL] [Abstract][Full Text] [Related]